Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, AcouSort AB's Enterprise Value is kr70.08 Mil.
AcouSort AB's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 was kr-9.86 Mil. Therefore, AcouSort AB's EV-to-EBIT ratio for today is -7.11.
EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA. As of today, AcouSort AB's Enterprise Value is kr70.08 Mil.
AcouSort AB's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 was kr-9.71 Mil. Therefore, AcouSort AB's EV-to-EBITDA ratio for today is -7.22.
EV-to-Revenue is calculated as Enterprise Value divided by its Revenue. As of today, AcouSort AB's Enterprise Value is kr70.08 Mil.
AcouSort AB's Revenue for the trailing twelve months (TTM) ended in Mar. 2026 was kr7.41 Mil. Therefore, AcouSort AB's EV-to-Revenue ratio for today is 9.46.
EV-to-FCF is calculated as Enterprise Value divided by its Free Cash Flow. As of today, AcouSort AB's Enterprise Value is kr70.08 Mil.
AcouSort AB's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 was kr-8.30 Mil. Therefore, AcouSort AB's EV-to-FCF ratio for today is -8.45.
*** Please note that the current Enterprise Value is calculated using the current market capitalization and the most recently available financial data. If key financial fields—Long-Term Debt & Capital Lease Obligation and Short-Term Debt & Capital Lease Obligation—are recorded as null in the latest reporting period, our data vendor will default to using data from the prior period with valid entries.
AcouSort AB (OSTO:ACOU) Enterprise Value Explanation
When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.
If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.
The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.
For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.
Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.
1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.
AcouSort AB's current Enterprise Value is kr70.08 Mil.
AcouSort AB's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was kr-9.86 Mil.
2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.
AcouSort AB's current Enterprise Value is kr70.08 Mil.
AcouSort AB's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was kr-9.71 Mil.
AcouSort AB's current Enterprise Value is kr70.08 Mil.
AcouSort AB's Revenue for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was kr7.41 Mil.
AcouSort AB's current Enterprise Value is kr70.08 Mil.
AcouSort AB's Cash Flow from Operations for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was kr-7.78 Mil.
AcouSort AB's current Enterprise Value is kr70.08 Mil.
AcouSort AB's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was kr-8.30 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
AcouSort AB Enterprise Value Related Terms
AcouSort AB Enterprise Value Historical Data
* Premium members only.
The historical data trend for AcouSort AB's Enterprise Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
OSTO:ACOU vs VRTX, REGN, ALNY: Enterprise Value Comparison
For the Biotechnology subindustry, AcouSort AB's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
AcouSort AB Enterprise Value vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, AcouSort AB's Enterprise Value distribution charts can be found below:
* The bar in red indicates where AcouSort AB's Enterprise Value falls into.
Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
AcouSort AB's Enterprise Value for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
AcouSort AB (OSTO:ACOU) has a Enterprise Value of kr70.08 Mil as of Jun. 28, 2026. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on AcouSort AB and its competitors.
Is AcouSort AB's Enterprise Value too high?
AcouSort AB's current Enterprise Value is kr70.08 Mil. Overall, AcouSort AB has a GF Score™ of 50/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does AcouSort AB's Enterprise Value compare to VRTX and REGN?
AcouSort AB's Enterprise Value of kr70.08 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Enterprise Value for a Biotechnology company?
A good Enterprise Value depends on the Biotechnology industry context. However, Enterprise Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Enterprise Value mean?
A high Enterprise Value can signal that a stock is expensive relative to its fundamentals. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on AcouSort AB and its competitors. AcouSort AB's current Enterprise Value is kr70.08 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is AcouSort AB stock overvalued right now?
Based on GuruFocus' analysis, AcouSort AB (OSTO:ACOU) is currently considered Possible Value Trap. The stock's GF Value™ is kr9.18, compared to a current price of kr4.00 — trading 56.4% below its estimated fair value. The current Enterprise Value is kr70.08 Mil. AcouSort AB's overall GF Score™ is 50/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Enterprise Value calculated?
Enterprise Value is calculated from a company's financial statements. For AcouSort AB (OSTO:ACOU), the current Enterprise Value is kr70.08 Mil as of Jun. 28, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is AcouSort AB (OSTO:ACOU) Overvalued in 2026?
Based on GuruFocus' analysis, AcouSort AB stock appears to be undervalued.
The current stock price of kr4.00 is trading 56.4% below its estimated GF Value™ of kr9.18.
GuruFocus considers AcouSort AB to be Possible Value Trap.
Key valuation signals for OSTO:ACOU:
Enterprise Value: kr70.08 Mil
GF Value™: kr9.18 vs. price of kr4.00 (56.4% below fair value)
No single metric tells the full story. See the OSTO:ACOU stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
AcouSort AB is a company that specializes in products and solutions for the automated preparation of biological samples for researchers and life science companies. Its technology is based on using ultrasound to isolate, separate, or trap microscopic particles such as blood cells, bacteria, or extracellular vesicles in microfluidic channels. The company's products includes AcouTrap, AcouWash, and AcouPlasma.
50GF Score
Get the complete analysis for OSTO:ACOU
Enterprise Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
OSTO:ACOU has been successfully added to your 
